PG
ELOS

PEAK6 Group’s Syneron Medical Ltd ELOS Stock Holding History

PEAK6 Group’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-10,481
Closed -$111K – 5380
2017
Q1 		$111K Buy
+10,481
New +$101K ﹤0.01% 3526
2015
Q3 		– Sell
-15,642
Closed -$166K – 5916
2015
Q2 		$166K Sell
15,642
-52,831
-77% -$619K ﹤0.01% 3903
2015
Q1 		$848K Buy
+68,473
New +$758K 0.01% 2047
2014
Q2 		– Sell
-10,900
Closed -$136K – 5478
2014
Q1 		$136K Sell
10,900
-8,300
-43% -$98.3K ﹤0.01% 3731
2013
Q4 		$236K Buy
+19,200
New +$199K ﹤0.01% 3385

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

PEAK6 Group's ELOS Position: Q2 2017 in Review

PEAK6 Group sold out of Syneron Medical Ltd (ELOS) in Q2 2017, closing a stake of 10,481 shares — an estimated $111K sold.

PEAK6 Group first reported a position in ELOS in Q4 2013 and held it in 5 quarters. The position peaked at $848K in Q1 2015. 79 funds tracked by Wall St. Rank hold ELOS as of Q2 2017.

  • PEAK6 Group reported no remaining Syneron Medical Ltd position as of Q2 2017 after selling out during the quarter.
  • PEAK6 Group sold 10,481 Syneron Medical Ltd shares in Q2 2017, an estimated $111K.
  • PEAK6 Group first reported a position in Syneron Medical Ltd in Q4 2013 and held it in 5 quarters.
  • PEAK6 Group's Syneron Medical Ltd position peaked at $848K in Q1 2015.
  • 79 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2017.

Based on PEAK6 Group's 13F filing for Q2 2017, filed 14 Aug 2017.